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In the present context of emergence of resistance aligned with the conventional anti-
leishmanial drugs and occasional treatment failure compelled us to continue the search
for  replaceable therapeutic leads against Leishmania infection. Various ginger spices of the
Zingiberaceae family are widely used as spices, ﬂavouring agents, and medicines in South-
east Asia because of their unique ﬂavour as well as due to their medicinal properties.
Zerumbone, a natural component of Zingiber zerumbet (L.) Smith, has been studied for its
pharmacological potential as antiulcer, antioxidant, anticancer, and antimicrobial. In this
study, we have shown that zerumbone could induce ROS mediated apoptosis in Leishmania
donovani promastigotes and also found effective in reducing intracellular amastigotes in
infected-macrophages. We  emphasized the potential of zerumbone to be employed in theROS development of new therapeutic drugs against L. donovani infection and provided the basis
for  future research on the application of transitional medicinal plants.
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eishmaniasis, a parasitic disease caused by protozoa of the
enus Leishmania, affects more  than 12 million people world-
ide. Treatment of leishmaniasis is based on pentavalent
ntimonials, drugs developed more  than 50 years ago that
re toxic and prone to drug resistance. Several drug screening
f natural compounds have been successful in discover-
ng novel compounds for treating some parasitic diseases.
xtracts obtained from plants, as well as pure compounds
ncluding terpenoids, ﬂavonoids (quercetin, rotenone) have
een reported to possess signiﬁcant antiprotozoal activities.
lants and natural products remain as the ideal resource in
earch for drug discovery because of their unique structural
iversity and promising long term safety records.1 Zingiber
erumbet (L.) Smith (awapuhi), also known as shampoo ginger
Malay = lempoyang)  or pinecone ginger is a vigorous species
f the ginger family with leafy stems growing to about 1.2 m
3.9 ft) tall. It is found in many  tropical countries. The rhizomes
f Z. zerumbet have been used as food ﬂavouring and appetiz-
rs in various cuisines while the rhizome extracts have been
sed in herbal medicine. In Hawaii, the fresh rhizomes were
sed as medicine for indigestion and other ailments. For a
oothache or a cavity, the cooked and softened ‘awapuhi’ rhi-
ome was pressed into the hollow and left for as long as was
eeded. To ease a stomach ache, the ground and strained rhi-
ome material is mixed with water and drunk. Zerumbone
as identiﬁed as a monocyclic sesquiterpene moiety [2,6,10-
y-cloundecatrien-1-one, 2,6,9,9-tetramethyl-,(E,E,E)-] of the
ssential component in rhizomes of Z. zerumbet (L.) Smith,
hows a variety of physiological effects e.g. anti-cancer, HIV
nhibitory, anti-inﬂammatory, anti-viral effects.2 Recently, our
eighbouring group indicated the anti-leishmanial effect of
ssential oil and zerumbone from Z. zerumbet (L.) Smith
gainst Leishmania donovani promastigotes.3 In this study,
e have shown that zerumbone could induce apoptosis by
isrupting oxidative axis and also effectively inhibited the
ntracellular amastigotes, pathogenic stage of the parasite in
ammalian host.
aterials  and  methods
xtraction  of  essential  oil  and  Puriﬁcation  of  zerumbone
he plant materials were collected from Manipur, North-East
ndia, 920 m from sea level, longitude 93◦58′′ and latitude
4◦44′′ in March, 2012. The plant was identiﬁed by the tax-
nomist of the institute and had given the accession number
s IBSD/Z-42-23. Fresh rhizomes were collected and washed
horoughly with tap water. These were cut into 5–6 mm slices
nd put into the Clevenger type oil extractor. Oil samples
ere analyzed by GC-FID on a Agilent 5975 C inert XL MSD.
he oil was dried over anhydrous sodium sulphate and
tored at 4 ± 2 ◦C. The oil was analyzed by GC–MS on a Varian
P-3800 GC coupled to a Varian Saturn 2000 MS/MS. The
C was equipped with a DB-5 fused silica capillary column
30 m × 0.25 mm,  with ﬁlm thickness of 0.25 m) operated
sing the following conditions: injector temperature, 240 ◦C,
olumn temperature, 60–240 ◦C at 3 ◦C/min, then held at 240 ◦C 1 6;2  0(1):48–55 49
for 5 min; carrier gas, He; injection volume, 1 L (splitless). The
MS mass ranged from 40 to 650 m/z, ﬁlament delay of 3 min,
target TIC of 20,000, a prescan ionization time of 100 s, an
ion trap temperature of 150 ◦C, manifold temperature of 60 ◦C,
and a transfer line temperature of 170 ◦C. The constituents of
the oil were identiﬁed using retention times, Kovats indices
and mass spectra. Conﬁrmed integrated peaks were then used
for the percentage of each chemical constituent present in the
essential oil. Kovats indices were calculated using the equa-
tion: KI(x) = 100[(log RT(x) − log Pz)/(log RT(Pz + 1) − log RT(Pz)],
where RT(Pz) ≤ RT(x) ≤ RT(Pz + 1), and P4, . . .,  P25 are n
parafﬁns.3,4
Parasites  maintenance  and  viability  assay
The anti-proliferative effect of zerumbone was estimated
on L. donovani AG83 (MHOM/IN/1983/AG83) as per the
guidelines of biosafety committee of West Bengal State
University. Promastigotes were transformed from splenic
intracellular amastigotes of infected BALB/c mice in com-
plete M199 medium (Invitrogen) supplemented with 1%
penicillin–streptomycin (Invitrogen) and 10% FCS (GIBCO)
at requisite temperature (22 ◦C). To estimate the per-
centage of inhibition, the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) micro method was used.
Brieﬂy, promastigotes cultures were incubated with or without
(control) increasing concentrations of zerumbone (0.1–50 M)
for 48 h in a 96-well ﬂat-bottom plate (200 L per well; BD Fal-
con) in complete M199 medium. After 48 h of incubation at
22 ◦C, MTT (10 mg/mL, 10 L per well) was added to each well
and the plates were incubated for another 4 h at 37 ◦C. The
reaction was then stopped with acidic isopropanol (0.4 mL
10 N HCl in 100 mL  isopropanol, 100 L per well), and the
absorbance was measured at 595 nm.5 The 50% inhibitory
concentration of zerumbone had been determined from the
plot of percent inhibition against increasing concentrations.
Cytotoxic effect was also evaluated on PHA (5 g/mL) stimu-
lated murine splenocytes (1 × 106 cells per well) cells without
(control) or with increasing concentrations of zerumbone
(0.1–50 M).
Analysis  of  cell  cycle  progression  in  L.  donovani
promastigotes
2.5 × 106 cells/mL exponential phase L. donovani AG83 pro-
mastigotes were incubated for 24 h and 48 h respectively in
complete M199 medium in the presence or absence of 50%
inhibitory concentration of zerumbone on promastigotes at
22 ◦C. After washing with 1× PBS, the cells were ﬁxed in 45%
ethanol (diluted in 1× PBS), treated with 500 g/mL RNAse A
and then suspended in 0.5 M sodium citrate containing 69 M
PI.6 Acquisition was performed using a ﬂow cytometer (BD
FACSVerseTM, BD Biosciences, USA) and the data were ana-
lyzed using Flowing software 2.5.
Externalization  of  phosphatidyl  serineIn order to study the apoptosis inducing capacity of zerum-
bone in promastigotes, the treated cells were stained with
Annexin V-PE and 7-AAD as per manufacturer’s instruction
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Fig. 1 – Anti-proliferative effect of zerumbone against L.
donovani-promastigotes and PHA induced murine
splenocytes with different concentrations of zerumbone
(0.1–50 M)  as determined by MTT  at 48 h and 96 h
respectively. Each point corresponds to the mean ± SD of at
least three experiments. Statistical signiﬁcance was
determined by one-way ANOVA followed by Holm–Sidak
4% (w/v), 1.0 mL/mouse) elicited peritoneal lavage of 6–8 weeks
old male BALB/c mice as per the guidelines of institutional ani-
mal  ethics committee of West Bengal State University. Cells50  b r a z j i n f e c t d
(BD Pharmingen). Brieﬂy, 2 × 106 log phase promastigotes were
incubated with IC50 concentration of zerumbone in triplicate
for 24 h and 48 h respectively. They were washed twice with
cold PBS and resuspended in 1× binding buffer at a concen-
tration of 1 × 106 mL−1. 100 L of the samples was transferred
to a fresh tube and Annexin V-PE (5 L), 7-AAD (5 L) were
added, incubated for 15 min  at RT in the dark. 400 L binding
buffer was added and cells were acquired in a ﬂow cytometer
(BD FACSVerseTM, BD Biosciences, USA) and analyzed using
Flowing 2.5 version software.5,7
Estimation  of  reactive  oxygen  species
In Leishmania,  oxidative stress has been suggested to be
responsible for the apoptotic process.5,6 To estimate the
level of ROS, the cell permeant probe H2DCFDA (2′,7′-
dichlorodihydroﬂuorescein diacetate) was used and analyzed
by ﬂow cytometer as described previously.5 H2DCFDA is a non-
ﬂuorescent dye which is converted into a ﬂuorescent DCF
(2′,7′-dichloroﬂuorescein) in the presence of proper oxidants
inside the cells. Promastigotes were treated with IC50 con-
centration of zerumbone and the induction of ROS had been
estimated at 1 h, 3 h, 5 h and 12 h by incubating with H2DCFDA
(20 M)  at room temperature for 20 min  in dark. H2O2 has been
used for positive control.6
Detection  of  chromatin  condensation  and  cytoplasmic  lipid
droplet  accumulation
The chromatin condensation and lipid accumulation in
zerumbone-treated promastigotes were detected under con-
focal microscope after staining with DAPI (2 g/mL) and Nile
Red (10 g/mL) as described earlier.5–8 Images were obtained
using an Olympus confocal laser scanning microscope (Model:
IX81) and analyzed by Olympus ﬂuoview version 3.0 viewer
software.
Measurement  of  total  lipid  peroxidation
As elevation of ROS is related with the increase in lipid per-
oxides, we  were keen to check the state of lipid peroxidation
in treated promastigotes. L. donovani promastigotes (107) were
treated with IC50 concentration of zerumbone for 1 h, 3 h and
5 h respectively. The cell-pellet was dissolved in 2 mL  of 15%
SDS-PBS solution. The ﬂuorescence intensities of the total
ﬂuorescent lipid peroxidation products were measured with
excitation at 360 nm and emission at 430 nm and expressed
as relative ﬂuorescence units with respect to quinine sulfate
(1 mg/mL  in 0.5 M H2SO4).6
Detection  of  the  change  in  morphology  by  scanning
electron  microscopyControl and treated promastigotes (2 × 106 cells) were ﬁxed
with 2.5% gluteraldehyde (Sigma Aldrich), dehydrated in
ethanol, critical point-dried in CO2, mounted on stubs, sput-
tered with a thin gold layer5,6 and observed under a scanning
electron microscope (Model: ZEISS EVO-MA 10).post hoc test (*p < 0.004, **p < 0.001, ***p  < 0.01 vs control).
Anti-proliferative  activity  on  intracellular  amastigotes
Peritoneal macrophages were isolated from thioglycolate (i.p.,Fig. 2 – Scanning electron microscopy was performed to
determine severe alterations in the morphology of
zerumbone treated L. donovani-promastigotes in
comparison to control culture. Images are representative
proﬁle of at least three independent experiments.
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Fig. 3 – Accumulation of cytosolic lipid in zerumbone-treated L. donovani AG83 promastigotes as evident by nile red staining
(magniﬁcation: 100×, zoom: 3.4×). (A) Phase contrast; (B) ﬂuorescence; (C) phase contrast–ﬂuorescence merge. Zerumbone
treatment signiﬁcantly increased lipid droplets accumulation (white arrows) in the cytosol in comparison to the untreated
cells. Images are representative proﬁle of at least three independent experiments.
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tere allowed to adhere in 8-chambered slides (105 cells per
ell) in complete RPMI-1640 at 37 ◦C in 5% CO2 environment
or 4 h. The subsequent steps of washing (3×  PBS) were per-
ormed to move out the nonadherent cells and granulocytes
nd then the cultures were continued for another 48 h with-
ut any manipulation.9,10 Adhered resting macrophages were
nfected with stationary phase of promastigotes (1:10), incu-
ated for 6 h, washed (2× PBS) to remove the uningested
romastigotes and cultured overnight in complete RPMI-1640
t 37 ◦C in 5% CO2 environment. Cells were washed (3×)  and
ncubated for additional 48 h in the presence or absence of
raded concentrations of zerumbone. Prechilled methanol-
xed cells were stained with Giemsa, and examined under
hase contrast microscope. At least 400 macrophages were
xamined for each set. Anti-leishmanial activity was deter-
ined by calculating the number of amastigotes per 100
acrophages.9,11
tatistical  analysestatistical analyses for all experiments were performed by
ne-way ANOVA followed by post hoc Holm–Sidak test with
he program Sigma Plot.Results
Analysis  of  phytochemicals
The yield of essential oil was 0.12%. GC–MS analyses of the
essential oil led to the identiﬁcation of ten major compounds
accounting for the 98.4% of the oil. Zerumbone (75.2%), -
caryophyllene (7.1%), camphene (5.1%), eucalyptol (2.4%), and
camphor (3.0%) were the major components of the oil were
identiﬁed in oil samples by Kovat analysis and comparison of
mass spectra with those reported in the NIST mass spectra
database (Supplementary Fig. 1). Compounds were quantiﬁed
by performing area percentage calculations based on the total
combined FID area. The percentage of a peak is a percent-
age relative to all other constituents integrated in the FID
chromatogram. The differences in chemical composition of
essential oil of the present study and previous research may be
because of the geographic and climatic factors, chemo types,
drying conditions and mode of distillation. Zerumbone was
isolated in pure form and its structure was conﬁrmed by 1H
NMR, 13C NMR, DEPT, HR-ESIMS and comparison with litera-
ture data.
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Fig. 4 – (A) Cell cycle progression in zerumbone treated promastigotes was assessed ﬂow cytometrically by Propidium
Iodide staining. Zerumbone induced cell death in promastigotes at 48 h by increasing the proportion of sub G0–G1 cells in
comparison to control culture. Data are representative of at least three independent experiments. (B) Zerumbone caused the
externalization of phosphatidyl serine as estimated by Annexin V and 7-AAD incorporation assay. The proportions of cells
at early apoptotic (Annexin V+ 7AAD−)  and late apoptotic phase (Annexin V+ 7AAD+) were  increased time dependently
ntagefollowing zerumbone treatment. Values represent the perce
representative of three independent experiments.
Zerumbone  inhibited  the  proliferation  of  L.  donovani
promastigotes
Zerumbone was found to inhibit the growth of Leishmania pro-
mastigotes dose dependently, in vitro. At a concentration of
10 M,  zerumbone inhibited the growth of L. donovani AG83
promastigotes approximately by 53.43%. Interestingly, the 50%
inhibitory concentration of zerumbone (9.36 M) could only
inhibit the proliferation of PHA induced murine splenocytes
by 5.75% even at 96 h (Fig. 1).
Zerumbone  induced  morphological  alterations  in  L.
donovani  promastigotes
The treated promastigotes appeared rounded with loss of ﬂa-
gella with porous cell membrane (Fig. 2B) in comparison to the
ﬂagellated and slender promastigotes of the control culture
(Fig. 2A).
Zerumbone  caused  lipid  accumulation  in  L.  donovani
promastigotes
Another prominent effect resulting from the treatment of the
promastigotes with zerumbone was the accumulation of lipid of positive cells at the respective quadrants. Data are
droplets in the cytoplasm (Fig. 3B and C), probably resulting
from the accumulation of lipid precursors due to the drastic
alteration of the sterol content in the parasite membrane. The
alteration in lipid contents as evidenced from the deposition
of lipid in the cytosol might also be correlated with plasma
membrane integrity, leading to apoptosis.
Zerumbone  altered  the  cell  cycle  progression  and  induced
externalization  of  phosphatidyl  serine  in  L.  donovani
promastigotes
At ﬁrst, we  have shown that the cell cycle progression of pro-
mastigotes was arrested at the sub-G0/G1 time dependently. At
24 h, the proportion of cells in the sub-G0/G1 was found only
2.9% in comparison to 1.6% of the control culture. Zerumbone
further increased sub-G0/G1 cells from 1.6% (untreated) to 9.9%
(treated) at 48 h accompanied by a decrease in the number of
cells in G0/G1 from 59.7% to 50.5% (Fig. 4A).
A signiﬁcant step of apoptosis is the translocation of phos-
phatidyl serine from the inner to the outer leaﬂet of the
plasma membrane.12 The externalization of phosphatidyl ser-
ine residues was observed in 1.39% (early apoptotic; Annexin
V only) and in 0.19% (late apoptotic; Annexin V+ 7AAD+) of
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Fig. 5 – Zerumbone induced DNA condensation as visualized after DAPI staining at 48 h. Images were  taken using an
Olympus ﬂuoview confocal microscope (Model: IX81) and analyzed by Olympus ﬂuoview ver.3.0 viewer software
(magniﬁcation: 100×, zoom: 3.4×). (A) Phase contrast; (B) ﬂuorescence; (C) phase contrast–ﬂuorescence merge. In untreated
promastigotes, the nuclei (K: kinetoplast; N: nucleus) appeared as distinct blue structure, whereas zerumbone treated
promastigotes showed blebbed nuclei and condensed chromatin material (white arrow). Images are representative proﬁle of
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ntreated promastigotes at 48 h. After the treatment with
erumbone (IC50 concentration) for 48 h, the percentage of
arly as well as late apoptotic cells was increased signiﬁcantly
ith respect to untreated cells. The percentage of Annexin
 positive cells (early apoptotic) increased to 15.7% at 48 h.
he percentage of Annexin V positive 7AAD stained cells
late apoptotic) increased to 7.58% at 48 h with respect to the
ntreated cells (Fig. 4B).
erumbone  caused  DNA  condensation  in  L.  donovani
romastigotes
API was used to measure DNA condensation in promastig-
tes. DAPI staining showed discrete nuclei (blue spots) in
ntreated promastigotes whereas the treated promastigotes
ere observed to have blebbed nuclei and condensed chro-
atin material (Fig. 5B and C).
erumbone  induced  the  oxidative  stress  in  L.  donovani
romastigotese  found that 50% inhibitory concentration of zerumbone
gainst promastigotes could increase the level of ROS time
ependently resulting in oxidative damage of the promastig-
tes (Fig 6A). The mean ﬂuorescence intensity (MFI) of ROSgeneration in treated promastigotes increased time depend-
ently in comparison to control culture (Fig. 6A).
Zerumbone  increased  the  level  of  lipid  peroxidation  in  L.
donovani  promastigotes
Zerumbone elevated the level of lipid peroxides in a time
dependent manner after 1 h of treatment and reached to max-
imum level at 12 h [control vs treatment – 492.14 vs 696.55]
(Fig. 6B).
Zerumbone  inhibited  the  intracellular  amastigotes  in
infected  macrophages
Zerumbone was found effective against intracellular amastig-
otes and the 50% inhibitory concentration was estimated with
the treatment of 5 M of zerumbone at 48 h (Fig. 7).
Discussion
Zerumbone is a naturally occurring dietary compound,
present in many  natural foods consumed today. The
compound derived from several plant species of the Zin-
giberaceae family that has been found to possess multiple
biomedical properties, such as antiproliferative, antioxidant,
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Fig. 7 – Zerumbone inhibited the proliferation of
intracellular amastigotes with an IC50 of only 5 M.
Thioglycolate-elicited peritoneal macrophages of BALB/c
mice were  infected in vitro with L. donovani AG83
promastigotes. After established infection, cells were
incubated with or without (control) graded concentrations
(0.5–10 M)  of zerumbone at 37 ◦C in 5% CO2 environment
for the determination of anti-leishmanial activity on
intracellular amastigotes. Each point corresponds to the
mean ± SD of at least three experiments in duplicate.
Statistical signiﬁcance was determined by one-way ANOVA
followed by Holm–Sidak post hoc test (*p < 0.001, **p < 0.002
vs infected control).anti-inﬂammatory, and anticancer activities.2 However, evi-
dence of efﬁcacy is sparse against protozoan infection to
support therapeutic claims to identify future uses against
L. donovani infection. In the present study we  successfully
analyzed the nature of zerumbone-mediated cell death in L.
donovani promastigotes and the possible key cellular medi-
ators involved in the death cascade. Our initial observation
that the zerumbone was effective against promastigotes but
substantially non-toxic towards murine splenocytes (Fig. 1)
made us curious for further in depth study. Morphological
structure as observed through SEM has also authenticated
the cytotoxic nature of zerumbone against Leishmania pro-
mastigotes (Fig. 2B and C) which can be correlated with the
unnatural lipid accumulation on treatment (Fig. 3B and C).
Interestingly, we found that zerumbone could increase the
sub-G0/G1 (dead cells) up to 9.9% from 1.6% as in control pro-
mastigotes (Fig. 4A), concomitantly caused the externalization
of phosphatidyl serine (Fig. 4B) in promastigote plasma mem-
brane which is a crucial step in the process of apoptosis.10
However, recently an interesting study raised the question on
relevance of Annexin V binding assay in detecting apopto-
sis in Leishmania as they showed that the promastigotes lack
phosphatidyl serine and Annexin V can also bind other lipids,
including phosphatidylcholine, phosphatidylethanolamine
and phosphatidylinositol.13 Accordingly, we  enquired the
effect of zerumbone on Leishmania chromatin condensation
and nuclear blebbing, the hallmark of apoptosis. The debate
regarding the induction of apoptosis by zerumbone has been
resolved and further conﬁrmed by the DNA condensation in
promastigotes (Fig. 5B and C). Looking into the mechanism, we
found that the oxidative stress (Fig. 6A) followed by an increase
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n the level of lipid peroxidation (Fig. 6B) in zerumbone-treated
romastigotes might involve the alteration of mitochondrial
embrane potential leading to apoptosis.14 The ultimate con-
iction came true when we  found that zerumbone inhibited
he clinically important morphs of L. donovani in mam-
alian host, the intracellular amastigotes in macrophages
Fig. 7). In conclusion, our ﬁndings indicate that zerumbone
nduced ROS-mediated apoptosis in L. donovani promastig-
tes and further pharmacological studies on this particular
nti-leishmanial efﬁcacy, in vivo, against L. donovani infection
ppear promising.
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